CONMED Corp
CNMDNYSECIK 816956HealthcareFiscal year ends Dec 31
Reports and events: 308 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-2916:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000816956-26-000102 |
| 2026-07-2916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000101 |
| 2026-06-1716:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002077096-26-000203 |
| 2026-06-0407:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001174947-26-000639 |
| 2026-06-0108:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0002077096-26-000190 |
| 2026-05-2008:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000816956-26-000057 |
| 2026-04-3009:52 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000816956-26-000053 |
| 2026-04-2916:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000051 |
| 2026-04-0708:23 ET | DEF 14A | Proxy statementPeriod 2026-05-18 | 0000816956-26-000047 |
| 2026-03-1316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-027658 |
| 2026-02-1711:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000816956-26-000009 |
| 2026-01-2816:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-26-000006 |
| 2026-01-1209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001174947-26-000024 |
| 2026-01-0817:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001174947-26-000017 |
| 2025-12-0508:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-118476 |
| 2025-11-0612:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000816956-25-000056 |
| 2025-11-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-25-000054 |
| 2025-09-0916:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001174947-25-001185 |
| 2025-08-0814:17 ET | 8-K | 8.01 Other events | 0000816956-25-000031 |
| 2025-07-3109:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000816956-25-000028 |
| 2025-07-3016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000816956-25-000026 |
| 2025-07-0717:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001174947-25-000987 |
| 2025-06-1616:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001174947-25-000941 |
| 2025-05-2116:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-25-000828 |
| 2025-05-0111:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000816956-25-000011 |
| 2025-04-3016:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-25-000654 |
| 2025-04-0816:05 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001193125-25-075693 |
| 2025-04-0116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001174947-25-000453 |
| 2025-02-2517:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001174947-25-000234 |
| 2025-02-1810:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000816956-25-000004 |
| 2025-02-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-25-000129 |
| 2025-01-1309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005046 |
| 2024-12-1009:03 ET | 8-K | 8.01 Other events | 0001174947-24-001328 |
| 2024-10-3108:52 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000816956-24-000018 |
| 2024-10-3016:09 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-247545 |
| 2024-10-0408:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-232621 |
| 2024-09-3011:45 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-228650 |
| 2024-09-2017:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-222986 |
| 2024-08-1416:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-200674 |
| 2024-08-0916:11 ET | 8-K | 8.01 Other events | 0001174947-24-000987 |
| 2024-08-0110:40 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000816956-24-000015 |
| 2024-07-3116:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-24-000936 |
| 2024-05-2816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001174947-24-000761 |
| 2024-05-2217:12 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-24-064334 |
| 2024-04-2509:52 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000816956-24-000006 |
| 2024-04-2416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-110117 |
| 2024-04-2416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001174947-24-000582 |
| 2024-04-0806:46 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001193125-24-089093 |
| 2024-02-2808:57 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000816956-24-000003 |
| 2024-02-2716:37 ET | 8-K | 8.01 Other events | 0001174947-24-000261 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.